https://doi.org/10.4081/jbr.2025.14017
A case report on a possible link between SARS-CoV-2 infection and gastric pathology onset
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 21 July 2025
Many organs have been described as involved in long-COVID processes. Concerning the stomach, few cases have been reported and discussed. Particularly, we have very few information about the potential direct damage to the gastric mucosa caused by SARS-CoV-2. We report the case of a 45-year-old Italian woman with no known chronic diseases or food intolerances who developed severe gastrointestinal manifestations as long COVID-19 manifestation following a SARS-CoV-2 infection. During the acute phase of COVID-19, she exhibited, among other symptoms including respiratory ones, an intense vasculitis affecting the superficial veins of the lower limbs and near-total desquamation of the lingual epithelium. Treatment with corticosteroids (betamethasone) led to complete remission in a few days. However, after recovery, she suddenly developed worsening heartburn and esophageal reflux. A year later, she was diagnosed with severe gastritis and mild dysplasia of the gastric body. Anamnesis revealed new-onset food intolerances to gluten-containing food and dairy foods. Histological examination showed Helicobacter pylori (HP) infection. After eradication therapy and dietary modifications, her gastric inflammation regressed, and dysplasia resolved. We hypothesize that SARS-CoV-2 may have triggered disruption of the gastric mucosa homeostasis, in turn leading to both food intolerances and HP proliferation. This case raises the question of whether SARS-CoV-2-induced molecular mimicry mechanisms may have long-term consequences on the gastric muco-microbiotic layer and in turn on the whole gastric homeostasis.
Downloads
Pizuorno A, Brim H, Ashktorab H. Gastrointestinal manifestations and SARS-CoV-2 infection. Curr Opin Pharmacol 2021;61:114-9. DOI: https://doi.org/10.1016/j.coph.2021.09.005
Cadamuro AC, Rossi AF, Maniezzo NM, Silva AE. Helicobacter pylori infection: host immune response, implications on gene expression and microRNAs. World J Gastroenterol 2014;20:1424-37. DOI: https://doi.org/10.3748/wjg.v20.i6.1424
Yi M, Chen S, Yi X, et al. Helicobacter pylori infection process: from the molecular world to clinical treatment. Front Microbiol 2025;16:1541140. DOI: https://doi.org/10.3389/fmicb.2025.1541140
Jukic I, Vukovic J. The challenges of treating a Helicobacter pylori infection following the COVID-19 pandemic in Croatia: A review. J Clin Med 2024;13:5762. DOI: https://doi.org/10.3390/jcm13195762
Nakov R, Dimitrova-Yurukova D, Snegarova V, et al. Increased prevalence of gastrointestinal symptoms and disorders of gut-brain interaction during the COVID-19 pandemic: An internet-based survey. Neurogastroenterol Motil 2022;34:e14197. DOI: https://doi.org/10.1111/nmo.14197
Barone R, Marino Gammazza A, Paladino L, et al. Morphological alterations and stress protein variations in lung biopsies obtained from autopsies of COVID-19 subjects. Cells 2021;10:3136. DOI: https://doi.org/10.3390/cells10113136
Angileri F, Legare S, Marino Gammazza A, et al. Molecular mimicry may explain multi-organ damage in COVID-19. Autoimmun Rev 2020;19:102591. DOI: https://doi.org/10.1016/j.autrev.2020.102591
Cappello F, Marino Gammazza A, Dieli F, et al. Does SARS-CoV-2 Trigger stress-induced autoimmunity by molecular mimicry? A hypothesis. J Clin Med 2020;9:2038. DOI: https://doi.org/10.3390/jcm9072038
Marino Gammazza A, Légaré S, Lo Bosco G, et al. Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19. Cell Stress Chaperones 2020;25:737-41. DOI: https://doi.org/10.1007/s12192-020-01148-3
Marino Gammazza A, Légaré S, Lo Bosco G, et al. Molecular mimicry in the post-COVID-19 signs and symptoms of neurovegetative disorders? Lancet Microbe 2021;2:e94. DOI: https://doi.org/10.1016/S2666-5247(21)00033-1
D'Anna SE, Vitale AM, D'Amico G, et al. Autoimmunity against nucleus ambiguous is putatively possible in both long-COVID-19 and vaccinated subjects: scientific evidence and working hypothesis. Biology (Basel) 2024;13:359. DOI: https://doi.org/10.3390/biology13060359
Manna OM, Caruso Bavisotto C, Gratie MI, et al. Targeting Helicobacter pylori through the "muco-microbiotic layer" lens: the challenge of probiotics and microbiota nanovesicles. Nutrients 2025;17:569. DOI: https://doi.org/10.3390/nu17030569
Lerner A, Benzvi C, Vojdani A. SARS-CoV-2 gut-targeted epitopes: sequence similarity and cross-reactivity join together for molecular mimicry. Biomedicines 2023;11:1937. DOI: https://doi.org/10.3390/biomedicines11071937
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.